4.1 Article

MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas

Journal

GENE EXPRESSION PATTERNS
Volume 9, Issue 4, Pages 193-199

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.gep.2008.12.003

Keywords

MicroRNA; miR-7; Human fetal pancreas; Pancreatic islets; Endocrine cells; Insulin; Glucagon; Neurogenin3; In situ hybridization

Funding

  1. National Institutes of Health-NCRR-Islet Cell Resources [U42 RR016603]
  2. Diabetes Research Institute Foundation
  3. Karasik Foundation
  4. Peacock Foundation and the Foundation for Diabetes Research

Ask authors/readers for more resources

MicroRNAs (miRNA) are small non-coding RNAs that inhibit gene expression through binding to complementary messenger RNA sequences. miRNAs have been predicted to target genes important for pancreas development, proper endocrine cell function and metabolism. We previously described that miRNA-7 (miR-7) was the most abundant and differentially expressed islet miRNA, with 200-fold higher expression in mature human islets than in acinar tissue. Here we have analyzed the temporal and spatial expression of miR-7 in human fetal pancreas from 8 to 22 weeks of gestational age (wga). Human fetal (8-22 wga) and adult pancreases were processed for immunohistochemistry, in situ hybridization, and quantitative RT-PCR of miRNA and mRNA. miR-7 was expressed in the human developing pancreas from around 9 wga and reached its maximum expression levels between 14 and 18 wga, coinciding with the exponential increase of the pancreatic endocrine hormones. Throughout development miR-7 expression was preferentially localized to endocrine cells and its expression persisted in the adult pancreas. The present study provides a detailed analysis of the spatiotemporal expression of miR-7 in developing human pancreas. The specific localization of miR-7 expression to fetal and adult endocrine cells indicates a potential role for miR-7 in endocrine cell differentiation and/or function. Future functional studies of a potential role for miR-7 function in islet cell differentiation and physiology are likely to identify novel targets for the treatment of diabetes and will lead to the development of improved protocols for generating insulin-producing cells for cell replacement therapy. (c) 2008 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available